Sotera Health Company $SHC Holdings Raised by Two Seas Capital LP

Two Seas Capital LP raised its position in Sotera Health Company (NASDAQ:SHC) by 4.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,111,053 shares of the company’s stock after buying an additional 275,000 shares during the period. Sotera Health makes up about 1.3% of Two Seas Capital LP’s holdings, making the stock its 10th biggest holding. Two Seas Capital LP owned approximately 2.14% of Sotera Health worth $112,993,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Darsana Capital Partners LP lifted its stake in shares of Sotera Health by 3.8% in the second quarter. Darsana Capital Partners LP now owns 27,000,000 shares of the company’s stock worth $479,250,000 after acquiring an additional 1,000,000 shares in the last quarter. BlackRock Inc. acquired a new stake in Sotera Health during the 2nd quarter valued at approximately $428,635,000. Sculptor Capital LP purchased a new stake in Sotera Health during the 2nd quarter worth approximately $426,000,000. Sachem Head Capital Management LP increased its holdings in Sotera Health by 47.2% during the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after purchasing an additional 3,735,000 shares during the last quarter. Finally, Jupiter Topco LLC acquired a new position in shares of Sotera Health in the 2nd quarter valued at approximately $149,137,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Sotera Health news, Chairman Michael Petras, Jr. sold 850,000 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares of the company’s stock, valued at $73,433,770.50. This trade represents a 17.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michael Rutz sold 150,000 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the sale, the insider owned 334,279 shares in the company, valued at $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,294,515 shares of company stock worth $23,999,528 over the last quarter. Insiders own 15.36% of the company’s stock.

Sotera Health Stock Performance

Shares of Sotera Health stock traded down $0.30 during trading hours on Tuesday, reaching $18.25. The company’s stock had a trading volume of 1,654,087 shares, compared to its average volume of 2,744,565. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85. The company’s 50 day simple moving average is $18.69 and its 200 day simple moving average is $16.94. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The stock has a market cap of $5.21 billion, a P/E ratio of 32.02 and a beta of 1.85.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The firm had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same quarter in the prior year, the business earned $0.20 earnings per share. Sotera Health’s quarterly revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, analysts expect that Sotera Health Company will post 0.87 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on SHC shares. JPMorgan Chase & Co. raised their price target on shares of Sotera Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Citigroup upped their price target on shares of Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a report on Friday, August 7th. Piper Sandler reissued an “overweight” rating and set a $25.00 price objective on shares of Sotera Health in a report on Tuesday, September 8th. UBS Group set a $19.00 target price on shares of Sotera Health in a research report on Wednesday, June 24th. Finally, Weiss Ratings raised shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $21.50.

About Sotera Health

Sotera Health Company (NASDAQ:SHC) is a global provider of healthcare services focused on sterilization, laboratory testing and infection prevention. The company serves medical device manufacturers, pharmaceutical companies, biotechnology businesses, hospitals and other healthcare organizations.

Sotera Health operates through three primary businesses. Sterigenics provides outsourced sterilization and medical device services using technologies such as ethylene oxide, gamma irradiation and electron beam processing.